DC10565 |
PX-102(PX-20606) |
PX20606, also known as PX-102, is a FXR agonist. |
|
DC7486 |
PX-478 2HCL
Featured
|
PX-478 is an inhibitor of HIF-1a with an IC50 of 20-30μM enhances radiosensitivity of prostate carcinoma cells. |
|
DC20519 |
Pyk2-IN-25a |
Pyk2-IN-25a is a highly potent Pyk2 (PTK2B) inhibitor with IC50 of 0.67 nM, dispalys 2-fold weakening potency for FAK (IC50=1.26 nM). |
|
DC23668 |
PyP-1 |
PyP-1 is a potent, highly selective, and orally bioavailable PDE10A inhibitor with Ki of 0.23 nM. |
|
DC7257 |
PYR 41
Featured
|
PYR-41 is a specific and cell permeable inhibitor of ubiquitin-activating enzyme E1 with an IC50 of < 10 uM, with no or little activity at E2. |
|
DC9636 |
Pyr6 |
Pyr6 is a selective inhibitor of TRPC3 with IC50 of 0.49 uM(Ca2+ influx inhibition in thapsigargin depleted native RBL-2H3 cells).
|
|
DCAPI1405 |
Pyrazinamide (Pyrazinoic acid amide) |
Pyrazinamide (Pyrazinoic acid amide) |
|
DC22202 |
Pyrazinib |
Pyrazinib (Pyrazinib (P3)) is a pyrazine phenol small molecule drug with anti-angiogenic and anti-metabolic activity in-vivo in zebrafish and in-vitro isogenic models of OAC radioresistance. |
|
DC8128 |
Pyridoclax(MR29072)
Featured
|
Pyridoclax(MR-29072) is a potent Mcl-1 inhibitor with Kd value of 25 nM. |
|
DC8091 |
Pyridostatin trifluoroacetate salt
Featured
|
Pyridostatin stabilizes G-quadruplexes, targeting the proto-oncogene SRC and telomeric G-quadruplexes, inducing DNA damage and cell-cycle arrest. |
|
DC20241 |
PIH(Pyridoxal isonicotinoyl hydrazine)
Featured
|
Pyridoxal isonicotinoyl hydrazine is a lipophilic, nontoxic, iron-chelating agent that shows high iron chelation efficacy both in vitro in cell culture models and in vivo in rats and mice. |
|
DC20154 |
Pyridoxine hydrochloride
Featured
|
Pyridoxine hydrochloride (Pyridoxol; Vitamin B6) is a pyridine derivative. Pyridoxine (Pyridoxol; Vitamin B6) exerts antioxidant effects in cell model of Alzheimer's disease via the Nrf-2/HO-1 pathway. |
|
DCAPI1553 |
Pyrimethamine |
Pyrimethamine is a potent inhibitor of multi-drug and toxin extrusion transporters. This compound inhibits Mdr-1(Pgp) and thus allows for active drugs to stay within the cell for longer periods of time, increasing their effectiveness by preventing efflux |
|
DC20520 |
Pyrimidinone 8 |
Pyrimidinone 8 is a novel allosteric, non-competitive divalent metal transporter-1 (SLC11A2/DMT1) inhibitor with Ki of 20 uM. |
|
DC21547 |
Pyrimidyn 7 |
Pyrimidyn 7 is a potent, dual-action dynamin GTPase activity inhibitor with IC50 of 1.1 uM/1.8 uM for dynamin I/dynamin II respectively, competitively inhibits both GTP and phospholipid interactions with dynamin. |
|
DC12084 |
Pyronaridine tetraphosphate
Featured
|
Pyronaridine tetraphosphate is a Mannich base anti-malarial with demonstrated efficacy against drug resistant Plasmodium falciparum, P. vivax, P. ovale and P. malariae. |
|
DC10691 |
Pyronaridine
Featured
|
Pyronaridine, also known as Malaridine, is an antimalarial drug. |
|
DC23125 |
Pyrotinib maleate
Featured
|
Pyrotinib maleate (SHR-1258 maleate) is a potent and selective EGFR/HER2 dual inhibitor with IC50 of 13/38 nM, respectively. |
|
DC10810 |
Pyrroloquinoline quinone (PQQ)
Featured
|
Pyrroloquinoline quinone (PQQ) is used as a cofactor (prosthetic group) for enzyme-catalyzed redox reactions of glucose and methanol dehydrogenase(s). |
|
DC20521 |
Pyrrophenone |
Pyrrophenone is a potent cPLA2α inhibitor with enzyme IC50 of 4.2 nM. |
|
DC9430 |
PYZD-4409 |
PYZD-4409 is a novel small molecule inhibitor of Ubiquitin-activating enzyme UBA1/E1 enzyme with an IC50 of 20 uM (cell-free enzymatic assay).
|
|
DC22197 |
PZ09(PKC-9)
Featured
|
PZ09 (PKC-zeta inhibitor 9, PKC-ζ inhibitor PZ9) is a potent, isoform selective PKC-zeta (PKC-ζ) inhibitor with IC50 of 5.18 nM, displays excellent selectivity (>200-fold) over other PKC isoforms with exception of PKC-i (10-fold). PZ09 also shows high selectivity for CDK-2 (>200-fold), as well as a broader range of other kinases (<50% inhibition at 10 uM). PZ09 is a small-molecule inhibitor, the first tool to successfully interrogate aPKC signaling in cells. |
|
DC12548 |
PZ-2891
Featured
|
PZ-2891 is a specific, allosteric, BBB-permeable, orally active Pantothenate kinase (PANK) modulator, acting as both an orthosteric inhibitor (IC50=1.3 nM, hPANK3) and an allosteric activator of PANK3 activity in the presence of acetyl-CoA in biochemical |
|
DC10290 |
PZM21
Featured
|
PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM. |
|
DC22203 |
Q151 |
Q151 is a highly potent inhibitor of mycobacterium tuberculosis IMPDH2 (MtbIMPDH2) with Kiapp of 18 nM, demonstrates the minimum inhibitory concentrations (MIC) of 1 uM withour significant cytotoxicity. |
|
DC11290 |
QC-3611
Featured
|
QC-3611 is a selective inhibitor of JARID1A/1B, which is a target existing in various tumors (JARID1A IC50 = 13 nM ;JARID1B IC50 = 2 nM). QC-3611 is promisingly to be used as an antineoplastic drug. |
|
DC21548 |
QC-6352 |
QC-6352 is a potent and selective KDM4 family inhibitor with IC50 of 104, 56, 35, and 104 nM for KDM4A, KDM4B, KDM4C, and KDM4D, respectively. |
|
DC11041 |
QCA276 |
QCA276 is a novel potent BET proteins inhibitor with IC50/Ki of 10/.3 nM, QCA276 is the BET ligand for PROTAC QCA570. |
|
DC11040 |
QCA570 |
QCA570 is a novel, highly potent efficacious BET degrader (PROTAC). |
|
DC10684 |
QCC-374
Featured
|
QCC-374 is prostanoid agonist potentially for the treatment of pulmonary arterial hypertension. |
|